Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Virus Like Particles market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Virus Like Particlesmarket, defines the market attractiveness level of Virus Like Particles market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Virus Like Particles industry, describes the types of Virus Like Particles market, the applications of major players and the market size, and deeply analyzes the current situation of the global Virus Like Particles market and the development prospects and opportunities of Virus Like Particles industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Virus Like Particles market in Chapter 13.
By Player:
Agilvax
Novavax
Cytos Biotechnology
ANGANY Genetics
GeoVax Labs
MedImmune
TechnoVax
Merck
Xiamen Innovax Biotech
Medicago
Allergy Therapeutics
Serum Institute of India
GlaxoSmithKline
Takeda
CPL Biologicals
By Type:
Adeno-associated Virus
HIV
Hepatitis B Virus
Hepatitis C Virus
Other
By End-User:
Vaccines
Mycoviruses
Virus Research
Therapeutic and Imaging Agents
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Virus Like Particles Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Virus Like Particles Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Virus Like Particles Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Virus Like Particles Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Virus Like Particles Market Analysis and Outlook to 2022
-
7.1 Global Virus Like Particles Consumption (2017-2022)
-
7.2 United States Virus Like Particles Consumption (2017-2022)
-
7.3 Europe Virus Like Particles Consumption (2017-2022)
-
7.4 China Virus Like Particles Consumption (2017-2022)
-
7.5 Japan Virus Like Particles Consumption (2017-2022)
-
7.6 India Virus Like Particles Consumption (2017-2022)
-
7.7 South Korea Virus Like Particles Consumption (2017-2022)
8 Region and Country-wise Virus Like Particles Market Analysis and Outlook to 2028
-
8.1 Global Virus Like Particles Consumption Forecast (2022-2028)
-
8.2 United States Virus Like Particles Consumption Forecast (2022-2028)
-
8.3 Europe Virus Like Particles Consumption Forecast (2022-2028)
-
8.4 China Virus Like Particles Consumption Forecast (2022-2028)
-
8.5 Japan Virus Like Particles Consumption Forecast (2022-2028)
-
8.6 India Virus Like Particles Consumption Forecast (2022-2028)
-
8.7 South Korea Virus Like Particles Consumption Forecast (2022-2028)
9 Global Virus Like Particles Market Outlook by Types and Applications to 2022
-
9.1 Global Virus Like Particles Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Adeno-associated Virus Consumption and Growth Rate (2017-2022)
-
9.1.2 Global HIV Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Hepatitis B Virus Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Hepatitis C Virus Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Virus Like Particles Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Vaccines Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Mycoviruses Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Virus Research Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Therapeutic and Imaging Agents Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Other Consumption and Growth Rate (2017-2022)
10 Global Virus Like Particles Market Outlook by Types and Applications to 2028
-
10.1 Global Virus Like Particles Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Adeno-associated Virus Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global HIV Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Hepatitis B Virus Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Hepatitis C Virus Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Virus Like Particles Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Mycoviruses Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Virus Research Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Therapeutic and Imaging Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Virus Like Particles Import and Export Analysis (Top 5 Countries)
-
11.1 Global Virus Like Particles Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Virus Like Particles Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Virus Like Particles Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Virus Like Particles Market Competitive Analysis
-
14.1 Agilvax
-
14.1.1 Agilvax Company Details
-
14.1.2 Agilvax Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Agilvax Virus Like Particles Product and Service
-
14.2 Novavax
-
14.2.1 Novavax Company Details
-
14.2.2 Novavax Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novavax Virus Like Particles Product and Service
-
14.3 Cytos Biotechnology
-
14.3.1 Cytos Biotechnology Company Details
-
14.3.2 Cytos Biotechnology Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Cytos Biotechnology Virus Like Particles Product and Service
-
14.4 ANGANY Genetics
-
14.4.1 ANGANY Genetics Company Details
-
14.4.2 ANGANY Genetics Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 ANGANY Genetics Virus Like Particles Product and Service
-
14.5 GeoVax Labs
-
14.5.1 GeoVax Labs Company Details
-
14.5.2 GeoVax Labs Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GeoVax Labs Virus Like Particles Product and Service
-
14.6 MedImmune
-
14.6.1 MedImmune Company Details
-
14.6.2 MedImmune Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 MedImmune Virus Like Particles Product and Service
-
14.7 TechnoVax
-
14.7.1 TechnoVax Company Details
-
14.7.2 TechnoVax Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 TechnoVax Virus Like Particles Product and Service
-
14.8 Merck
-
14.8.1 Merck Company Details
-
14.8.2 Merck Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Merck Virus Like Particles Product and Service
-
14.9 Xiamen Innovax Biotech
-
14.9.1 Xiamen Innovax Biotech Company Details
-
14.9.2 Xiamen Innovax Biotech Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Xiamen Innovax Biotech Virus Like Particles Product and Service
-
14.10 Medicago
-
14.10.1 Medicago Company Details
-
14.10.2 Medicago Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Medicago Virus Like Particles Product and Service
-
14.11 Allergy Therapeutics
-
14.11.1 Allergy Therapeutics Company Details
-
14.11.2 Allergy Therapeutics Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Allergy Therapeutics Virus Like Particles Product and Service
-
14.12 Serum Institute of India
-
14.12.1 Serum Institute of India Company Details
-
14.12.2 Serum Institute of India Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Serum Institute of India Virus Like Particles Product and Service
-
14.13 GlaxoSmithKline
-
14.13.1 GlaxoSmithKline Company Details
-
14.13.2 GlaxoSmithKline Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 GlaxoSmithKline Virus Like Particles Product and Service
-
14.14 Takeda
-
14.14.1 Takeda Company Details
-
14.14.2 Takeda Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Takeda Virus Like Particles Product and Service
-
14.15 CPL Biologicals
-
14.15.1 CPL Biologicals Company Details
-
14.15.2 CPL Biologicals Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 CPL Biologicals Virus Like Particles Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Virus Like Particles
-
Figure Virus Like Particles Picture
-
Table Global Virus Like Particles Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Virus Like Particles Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Virus Like Particles Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Virus Like Particles Consumption by Country (2017-2022)
-
Figure United States Virus Like Particles Consumption and Growth Rate (2017-2022)
-
Table Europe Virus Like Particles Consumption and Growth Rate (2017-2022)
-
Figure China Virus Like Particles Consumption and Growth Rate (2017-2022)
-
Figure Japan Virus Like Particles Consumption and Growth Rate (2017-2022)
-
Figure India Virus Like Particles Consumption and Growth Rate (2017-2022)
-
Figure South Korea Virus Like Particles Consumption and Growth Rate (2017-2022)
-
Figure Global Virus Like Particles Consumption Forecast by Country (2022-2028)
-
Figure United States Virus Like Particles Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Virus Like Particles Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Virus Like Particles Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Virus Like Particles Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Virus Like Particles Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Virus Like Particles Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adeno-associated Virus Consumption and Growth Rate (2017-2022)
-
Figure Global HIV Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis B Virus Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis C Virus Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Mycoviruses Consumption and Growth Rate (2017-2022)
-
Figure Global Virus Research Consumption and Growth Rate (2017-2022)
-
Figure Global Therapeutic and Imaging Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Adeno-associated Virus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HIV Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis B Virus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis C Virus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mycoviruses Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Virus Research Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapeutic and Imaging Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Virus Like Particles Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Virus Like Particles Export by Region (Top 5 Countries) (2017-2028)
-
Table Agilvax (Foundation Year, Company Profile and etc.)
-
Table Agilvax Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agilvax Virus Like Particles Product and Service
-
Table Novavax (Foundation Year, Company Profile and etc.)
-
Table Novavax Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novavax Virus Like Particles Product and Service
-
Table Cytos Biotechnology (Foundation Year, Company Profile and etc.)
-
Table Cytos Biotechnology Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cytos Biotechnology Virus Like Particles Product and Service
-
Table ANGANY Genetics (Foundation Year, Company Profile and etc.)
-
Table ANGANY Genetics Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
Table ANGANY Genetics Virus Like Particles Product and Service
-
Table GeoVax Labs (Foundation Year, Company Profile and etc.)
-
Table GeoVax Labs Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
Table GeoVax Labs Virus Like Particles Product and Service
-
Table MedImmune (Foundation Year, Company Profile and etc.)
-
Table MedImmune Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
Table MedImmune Virus Like Particles Product and Service
-
Table TechnoVax (Foundation Year, Company Profile and etc.)
-
Table TechnoVax Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
Table TechnoVax Virus Like Particles Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Virus Like Particles Product and Service
-
Table Xiamen Innovax Biotech (Foundation Year, Company Profile and etc.)
-
Table Xiamen Innovax Biotech Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
Table Xiamen Innovax Biotech Virus Like Particles Product and Service
-
Table Medicago (Foundation Year, Company Profile and etc.)
-
Table Medicago Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medicago Virus Like Particles Product and Service
-
Table Allergy Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Allergy Therapeutics Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergy Therapeutics Virus Like Particles Product and Service
-
Table Serum Institute of India (Foundation Year, Company Profile and etc.)
-
Table Serum Institute of India Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
Table Serum Institute of India Virus Like Particles Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Virus Like Particles Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Virus Like Particles Product and Service
-
Table CPL Biologicals (Foundation Year, Company Profile and etc.)
-
Table CPL Biologicals Virus Like Particles Sales, Price, Value and Gross Profit (2017-2022)
-
Table CPL Biologicals Virus Like Particles Product and Service
-
